Compare uniQure N.V. Ordinary Shares (QURE) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs United States Oil ETF — how do they compare? uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B), while United States Oil ETF trades at $153.65 (market cap $1.86B). The key difference: United States Oil ETF is the larger of the two by market cap, and United States Oil ETF is trading nearer its 52-week high, uniQure N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and United States Oil ETF for 21 Days on average.
| QURE | USO | |
|---|---|---|
Market Cap | $1.48B | $1.86B |
Volume | 2,488,780 | 3,642,169 |
Sector | Health | — |
52-Week High | $70.59 | $161.86 |
52-Week Low | $9.03 | $66.17 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $728.62M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
USO trades at $153.09, up 1.36% with a bullish technical signal supported by moving averages. Recent Middle East tensions and OPEC+ production decisions create volatility in oil markets, though G-7 reserve releases aim to curb prices. The stock shows strong technical momentum with key resistance at $154.
Outlook remains volatile with geopolitical risks balanced against supply interventions. Investment opportunity exists for traders capitalizing on oil price swings, though regulatory and operational risks persist. The stock's performance remains tightly linked to crude oil price movements and global supply dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
